AMS Newsletter 18 December 2024

In this edition

• Updated AMS Information Sheet - Surgical Menopause
• AMS Congress 2025 - Fremantle WA
• Menopausal Hormone Therapy (MHT) discontinuation and shortages December 2024
• Oral Health and Menopause: Exploring the Views and Practices of General Practitioners and Practice Nurses

Health Professionals - join AMS for Members-only content 

• Menopause Matters
• TMS Video - Cognitive-Behavioral Therapy for Managing Menopause Symptoms
• European Menopause and Andropause Society (EMAS) Newsletter
• Missed Out on the 19th World Congress on Menopause? Join IMS2024 On Demand!

In this edition 

Updated AMS Information Sheet - Surgical Menopause

This factsheet stresses how important it is that any patient experiencing a premature or early menopause, whether naturally, due to medications or due to surgery, sees a specialist in early menopause management. Patients experiencing earlier menopause are at higher risk of chronic health issues going forward, so there is much more to consider for these patients than menopause symptom management alone. This factsheet discusses these points.

See AMS Surgical Menopause online here  

AMS Congress 2025 - Fremantle WA

AMS’s annual 27th conference will be held in Fremantle 12-14th September next year. Registrations will open early in the New Year.

The Annual Congress is a perfect opportunity to network and to become acquainted with the latest information on managing the menopause.

With women’s midlife health being at the forefront of media attention, the challenge is to deliver the most effective tools for physiological changes and to manage symptoms that may offer an opportunity to mitigate long-term health outcomes.

The IMS World Congress in Melbourne in October in 2024 was a huge success. The AMS Congress will offer further opportunity to ask questions and discuss patient care, spreading the diversity and implementation of that care.

Board member and Endocrinologist, Ashley Makepeace from Fremantle, is chairing the Scientific Committee. It promises to be an outstanding Scientific Congress with new themes and objectives.

Fremantle is a vibrant city with outstanding natural surrounding resources for your enjoyment pre or post Congress.

I look forward to seeing you there. I encourage you to send ’Suggestions for Fremantle Congress’ to ams@menopause.org.au.

Yours sincerely,

Dr Sylvia Rosevear 

Menopausal Hormone Therapy (MHT) discontinuation and shortages December 2024

Australia 

Patch Shortages

There are a number of MHTs that are currently unavailable. Please note that the TGA has approved some unregistered products under Section 19A and some substitute doses are currently in supply in Australia. Pharmacists are encouraged to contact suppliers Medsurge Healthcare Pty Ltd on 1300 788 261 for orders of Estramon and Sandoz on 1800 726 369 for orders of Estradiol Transdermal System.

Oestradiol patches

	Expected supply due		Alternative supply under Section 19A
Dose	Estradot	Estraderm	Estramon	Estradiol Transdermal System
25 mcg	31 Dec 2025	16 Dec 2024	Available
37.5 mcg	30 Jun 2025		Available	Available
50 mcg	31 Dec 2025	16 Dec 2024	Available	Unavailable
75 mcg	31 Dec 2025	16 Dec 2024	Available	Unavailable
100 mcg	31 Dec 2025	16 Dec 2024	Available	Available

Combined patches

Dose	Estalis Sequi	Estalis Conti
50/140	Limited	Limited
50/250	Limited	Limited

All doses of Climara have been deleted from the market and there will be a reduction in supply until supply is exhausted.

The AMS Guide to MHT Doses (Australia only) provides a guideline to approximately equivalent doses of the different MHT/HRT products in Australia.

New Zealand

As at 11 December 2024, patch availability is provided below.

Dose	Estradot	Viatris	Estraderm MX
25mcg	Low	Available	Available
50mcg	Low	Available
75mcg	Low	Available
100mcg	Low	Available

More information can be found here  

The AMS Guide to MHT Doses (New Zealand only) provides a guideline to approximately equivalent doses of the different MHT/HRT products in New Zealand.

Oral Health and Menopause: Exploring the Views and Practices of General Practitioners and Practice Nurses

About the study

Women are at higher risk of developing oral health problems during menopause. These oral health problems can significantly affect their quality of life. Studies have shown that healthcare providers can play a key role in addressing the oral health needs of women in perimenopause or menopause. However, very little is known about the current perceptions and practices of healthcare providers like General practitioners/Practice nurses for the management of oral health for women in perimenopause/menopause.

We invite you to participate in our study (interview) which aims to explore your experience regarding oral healthcare and identify challenges in this area. The information you provide will help us identify future strategies and services that could improve oral healthcare for women in perimenopause or menopause. Participation will involve a 20–30-minute interview. The interview will be conducted at a time convenient for you using either phone, online platforms like zoom, or face-to-face. Participation is voluntary and the information you provide will be strictly confidential. You will be reimbursed for your time participating in an interview.

Researchers

Australian Centre for Integration of Oral Health (ACIOH), Western Sydney University.

Ethics approval

This study has been approved by the Western Sydney University Human Research Ethics Committee. HREC Approval No: H15712

Contact

Namitha Thomas (Chief investigator and PhD student), Tel: +61 2 8738 9367,

Email: 20628260@student.westernsydney.edu.au

Please click here to register your interest : https://t.ly/3CoPJ

Health Professionals - join AMS for Members-only content 

Menopause Matters: Professor Athol Kent has reviewes and comments on recent journal articles.

TMS Video - Cognitive-Behavioral Therapy for Managing Menopause Symptoms 

European Menopause and Andropause Society (EMAS) Newsletter AMS is an affiliate of EMAS. See latest copy.

Missed Out on the 19th World Congress on Menopause? Join IMS2024 On Demand!

For those who couldn’t attend, you can view what you would like to at: IMS2024 On Demand. This gives you the chance to experience all sessions from the congress at your own pace.

How It Works:

• Purchase Credits: Buy the credits needed to access the On Demand content.
• Select Your Sessions: Choose from the available sessions based on your interests.
• Watch the Videos: Credits will be deducted as you access each session.

Lectures will be available for 12 months from November 11th, 2024, allowing you ample time to explore all the content.

Not Sure How Many Credits to Purchase? 

Check the program to estimate how many credits you might need. Don’t worry - you can always add more credits at any time!

Learn more and see the FAQs at https://imsmelbourne2024.com/ondemand/